Labu holdings.

All 142 LABU Holdings The LABU ETF, or Direxion Daily S&P Biotech Bull 3x Shares, is an investment product that allows you to invest in the biotechnology sector with leveraged exposure. This means the ETF aims to deliver three times (3x) the daily performance of its underlying index, the S&P Biotechnology Select Industry Index, which includes a diverse …

Labu holdings. Things To Know About Labu holdings.

LABU External Home Page Benchmark for LABU S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX The S&P Biotechnology Select Industry Index is designed …LABU cons. The following are LABU weaknesses from our perspective:. LABU net assets are $417.32 million. This fund is not a popular choice with retail investors. LABU 3-year return is -16.34%, which is lower than the 3-year return of the benchmark index (S&P 500 TR USD), 13.64%.; LABU 5-year return is -16.23%, which is lower than the 5-year return …The Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is issued by Direxion. Asset Class Equity.2018. $0.21. 2017. -. 2016. -. 2015. -. View the latest Direxion Daily S&P Biotech Bull 3X Shares (LABU.US) stock price and news, and other vital information for better exchange traded fund investing.

That's why LABU is designed for short-term trading, not long-term holding. About LABU. This 3X ETF has an inception date of March 28, 2015. Rafferty Asset Management actively manages it.AMAT. 3.98%. View Holdings As of 10/31/2023. iShares Semiconductor ETF ETF holdings by MarketWatch. View complete SOXX exchange traded fund holdings for better informed ETF trading.

Holdings. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies.

LABU DIREXION DAILY S&P BIOTECH BULL 3X SHARES ETF Asset Class Median; Volume (10-Day Avg) AS OF 06/01/2023: 33.6M: 59.6M: 1 Month Market Total Return AS OF 06/01/2023 ... Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments.Mar 22, 2023 · Top Holdings . LABU is diversified through 187 holdings, with the most significant being Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL), representing 3.67%, ... LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.Mar 31, 2022 · LABU has an expense ratio of 0.96 percent, which also is a reason behind such poor performance over the medium and long term. And because these ETFs invest in derivatives, these become further risky. LABU 107.48. Creates & Redeems. Largest 1-day activity. SOXL $-248,193,000.00. SPDN $230,092,000.00. SOXS $199,233,000.00. As of 11/30/2023. The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate.

CURE expense ratio is N/A. CURE holdings. Top 10 Holdings (53.71% of Total Assets). Name, Symbol, % Assets. Goldman ...

Nov 30, 2023 · The Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is issued by Direxion. Asset Class Equity.

Direxion Daily S&P Biotech Bull 3X ETF (LABU) scores better than many of its major competitors, with prior gain experiences at a rate above the day’s top 20 stocks average. Best Stock Selection ...Find exchange traded funds (ETFs) whose sector aligns with the same commodity grouping as the symbol you are viewing. Analysis of these related ETFs and how they are trading may provide insight to this commodity. ETF Constituents for S&P Biotech Bull 3X Direxion (LABU) provide detail on the individual stock holdings that make up the ETF. Holdings: 45: Inception Date: Nov 15, 2017: About PILL Fund Home Page The Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. ... Other symbols: CLDL CURE LABU NAIL SKYU WEBL. 1 year ago - ETF Trends.LABU's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. Home ... LABU - Holdings Concentration Analysis. LABU Category Low Category High LABU % Rank; Net Assets: 868 M: 845 K: 16.3 B: 6.55%: Number of Holdings: 151: 4: 2025: 21.47%: Net Assets in …LABU's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! ... LABU - Holdings Concentration Analysis. LABU Category Low Category High LABU ...

View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU).Learn how it impacts everything we do. LABU Portfolio - Learn more about the Direxion Daily S&P Biotech Bull 3X ETF investment portfolio including asset allocation, stock style, stock holdings and ... LABU Direxion Daily S&P Biotech Bull 3X Shares ETF Holdings and Sector Allocations 13.58K followers $3.58 0.12 ( +3.47%) 1:00 PM 11/24/23 NYSEARCA | $USD …LABU cons. The following are LABU weaknesses from our perspective:. LABU net assets are $417.32 million. This fund is not a popular choice with retail investors. LABU 3-year return is -16.34%, which is lower than the 3-year return of the benchmark index (S&P 500 TR USD), 13.64%.; LABU 5-year return is -16.23%, which is lower than the 5-year return …Aug 20, 2023 · LABU's Structure and Holdings. The LABU ETF primarily invests in derivatives, such as futures, options, and swaps, of companies in the biotech and life sciences sectors.

Agence immobilière Le Pavillion Edit. MrFouad Belamri. Show contact number. 56, Chemin Bachir Ibrahimi, el-BIAR,Poirson en face ambassade d'Italye, Algiers. Send message. …

Nov 21, 2023 · A high-level overview of Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools ... Learn everything you need to know about Direxion Daily S&P Biotech Bull 3X ETF (LABU) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see ...Among the largest underlying components of LABU, in trading today ALX Oncology Holdings Inc (NASDAQ:ALXO) is down about 4.7%, AbbVie Inc (NYSE:ABBV) is off about 0.6%, and Acadia Pharmaceuticals Inc (NASDAQ:ACAD) is higher by about 2.4%. For a complete list of holdings, visit the LABU Holdings page »Dec 1, 2023 · Start Free Trial. A list of holdings for LABU (Direxion Daily S&P Biotech Bull 3X Shares) with details about each stock and its percentage weighting in the ETF. DGCXX | A complete Dreyfus Government Cash Management;Institutional mutual fund overview by MarketWatch. View mutual fund news, mutual fund market and mutual fund interest rates.LABU cons. The following are LABU weaknesses from our perspective:. LABU net assets are $417.32 million. This fund is not a popular choice with retail investors. LABU 3-year return is -16.34%, which is lower than the 3-year return of the benchmark index (S&P 500 TR USD), 13.64%.; LABU 5-year return is -16.23%, which is lower than the 5-year return …Since Labu Holdings was incorporated in 1995, one would wonder where all the money went while Labuans remain as ordinary villagers with no access to basic services. There is a proposed Labu special economic zone by the Government to be developed at Labu Tali, much bigger than the Lae Tidal Basin.Dec 1, 2023 · About LABU. Fund Home Page. The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is issued by Direxion. Asset Class Equity. LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.Oct 12, 2018 · Can we stand up together now to re-establish Labu Holdings and our birthright as legitimate landowners of the Lae Port and the Lae Tidal Basin area and get a fair share? Labu Butu, Labu Miti and Labu Tale are just a few kilometres south from the lights of Lae City, across the Markham River, and yet we still live under our sago-thatch roofs ...

Index Top Ten Holdings % LABU. Direxion Daily S&P Biotech Bull 3X Shares. LABD. Direxion Daily S&P Biotech Bear 3X Shares *The Net Expense Ratio includes management fees, other operating expenses and Acquired Fund Fees and Expenses. If Acquired Fund Fees and Expenses were excluded, the Net Expense Ratio would be 0.95%. The

AMC AMC ENTERTAINMENT HOLDINGS, INC. ... ‎0.262 ‎-1.20%. GME GAMESTOP CORP. ‎15.39 ‎-6.50%. LABU NYSE ARCA • delayed by 15 minutes • CURRENCY IN USD. Direxion Daily S&P Biotech Bull 3X ...

Top 7 Holdings (7.94% of Total Assets) View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU).If you wish to receive a copy of the PortFolio, please write, call or email us at: ICTSI Public Relations Office, 2F ICTSI Administration Building, Manila International Container Terminal, MICT ...Check out LABU MarketBeat - Wed Mar 22, 8:00AM CDT. Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. Thee ETF industry is seeing explosive growth, piling up huge assets amid the stock market turmoil.Nov 24, 2023 · The Direxion Daily Healthcare Bull 3x Shares (CURE) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies. CURE was launched on Jun 15, 2011 and is issued by Direxion. Mar 22, 2023 · LABU is diversified through 187 holdings, with the most significant being Madrigal Pharmaceuticals Inc. NASDAQ: MDGL, representing 3.67%, followed by Arrowhead Pharmaceuticals Inc. NASDAQ: ARWR with 1.29% and Cytokinetics Inc. NASDAQ: CYTK at $1.23%. This is designed so that a single company will only impact the fund a little in cases of ... Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $7.07 at the beginning of 2023. Since then, LABU stock has decreased by 40.6% and is now trading ...Dec 1, 2023 · Start Free Trial. A list of holdings for LABU (Direxion Daily S&P Biotech Bull 3X Shares) with details about each stock and its percentage weighting in the ETF. LABU Direxion Daily S&P Biotech Bull 3X Shares ETF Holdings and Sector Allocations 13.58K followers $3.58 0.12 ( +3.47%) 1:00 PM 11/24/23 NYSEARCA | $USD …DGCXX | A complete Dreyfus Government Cash Management;Institutional mutual fund overview by MarketWatch. View mutual fund news, mutual fund market and mutual fund interest rates.With LABU trading at a recent price near $62.50 per unit, that means that analysts see 62.34% upside for this ETF looking through to the average analyst targets of the underlying holdings.View Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares's expense ratio, return performance, holdings, news, and more.Ve las principales participaciones y la información de las participaciones clave de Direxion Daily S&P Biotech Bull 3X Shares (LABU).

LABU is an exchange-traded fund (ETF) that aims to triple the daily return of the S&P Biotechnology Select Industry Index, a benchmark for the biotechnology sector. Learn more about the fund's portfolio composition, holdings, risks, and performance on Fidelity.Long Term Capital Gains Profits distributed to shareholders resulting from the sale of securities held in the fund’s portfolio for more than one year. Explore Direxion's leveraged and inverse and non-leveraged ETFs. Find the ETFs to meet your investment goals.Unlike a traditional ETF, LABU is not a collection of holdings designed to mirror an index. Instead, this fund is a daily 3x leveraged bet on the performance of the S&P Biotechnology Select ...Instagram:https://instagram. cost of a gold barbest stocks to buy as a beginnerhow to invest 3000 dollarsnasdaq acmr Find the latest Direxion Daily MSCI Emerging Markets Bull 3X Shares (EDC) stock quote, history, news and other vital information to help you with your stock trading and investing.LABU | A complete ... Hellman Jordan Management Co Inc Buys Tenable Holdings Inc, Cisco Systems Inc, iShares Biotechnology ETF, Sells Industrial Select Sector SPDR, Five9 Inc, ... affirm stock forecastfandg annuities and life stock Find exchange traded funds (ETFs) whose sector aligns with the same commodity grouping as the symbol you are viewing. Analysis of these related ETFs and how they are trading may provide insight to this commodity. ETF Constituents for S&P Biotech Bull 3X Direxion (LABU) provide detail on the individual stock holdings that make up the ETF. nyse mdu Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Daily S&P Biotech Bull 3X Shares (Symbol: LABU) where we have ...View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bear 3X Shares (LABD).Check out LABU MarketBeat - Wed Mar 22, 8:00AM CDT. Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. Thee ETF industry is seeing explosive growth, piling up huge assets amid the stock market turmoil.